Aimfinity Investment Corp. I (AIMAU) to Combine with Docter, Inc. in $60M Deal
Aimfinity I (NASDAQ:AIMAU) has entered into a definitive agreement to combine with medical device maker Docter for $60 million in share compensation. Kaohsiung, Taiwan-based Docter is developing a glucose-monitoring watch as a platform for recurring services and software revenue. The combined company is expected to trade on the Nasdaq once the deal is completed in
Read More
To access this post, you must purchase 1 - User: Monthly Plan.